BIOSYNEX
Climate Impact & Sustainability Data (2022-01 to 2022-06, 2023, 2023-01 to 2023-06, 2024-01 to 2024-06)
Reporting Period: 2022-01 to 2022-06
Environmental Metrics
Governance Achievements
- Renewed the mandates of President and CEO Larry Abensur and Deputy CEO Thierry Paper for six years until 2028.
- Renewed the mandate of Elie Fraenckel as administrator for six years until 2028.
- Reduced the company's capital by canceling treasury stock, in compliance with Article L.22-10-65 of the French Commercial Code.
Climate Goals & Targets
Environmental Challenges
- Decrease in Covid-19 related sales due to improved health situation and increased competition.
- Price increases imposed by suppliers and logistics providers due to the situation in Ukraine.
Mitigation Strategies
- Accelerated diversification strategy, resulting in a 27% increase in non-Covid-19 activity.
- Taking measures to preserve margins in the face of supplier price increases.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2023
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Significant decrease in Covid-19 product sales.
- Financial covenants breach.
- Liquidity risk.
- Integration challenges of acquisitions.
- Risks related to internationalization.
- Risks related to the development and success of new products.
- Risks related to healthcare systems.
- Risks related to regulations and various legislations.
Mitigation Strategies
- Diversification strategy.
- Discussions with lenders for waivers and debt restructuring.
- Seeking new external financing (equity/quasi-equity).
- Rigorous selection process for acquisitions and detailed integration plans.
- Legal and regulatory monitoring.
- Focus on integrating acquisitions and building centers of excellence.
- Aiming for profitability through growth, reduced costs, and operational efficiency.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2023-01 to 2023-06
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Significant decrease in COVID-19 sales (70% decrease compared to the first half of 2022).
- Liquidity risk due to high debt and potential non-compliance with financial covenants.
- Recall of microwavable hot water bottles due to fire and burn risks.
Mitigation Strategies
- Continued implementation of a transformation plan, including diversification of the DIAGNOSTIC division and continued commercialization of prevention and family health products in the PHARMACIE division.
- Negotiations with the banking pool to obtain a waiver for non-compliance with financial covenants.
- Discontinuation of the sale of the recalled hot water bottles and a reevaluation of the risk associated with the recall.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2024-01 to 2024-06
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Established a CSR (Corporate Social Responsibility) committee.
Governance Achievements
- Appointed Diane Bessin and Brigitte Geny as directors.
- Created a CSR committee.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Liquidity risk due to high debt levels and potential non-compliance with financial covenants.
- Integration of US activities which remain deficit.
- Destruction of expired Covid-19 stocks.
Mitigation Strategies
- Initiated discussions with lenders for debt restructuring (maturity extension, covenant flexibility).
- Implemented cost reduction measures and synergy deployment, leading to a 10% reduction in workforce.
- Rationalization of US industrial activities, including the planned closure of the PROCISEDX site in February 2025.
- Restructuring of US commercial activities.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: IVDR certification for a biotherapy monitoring test.
Third-party Assurance: Deloitte & Associés (limited review)
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed